In troubling decision, FDA contracts with company that may have profited from fetal tissue sales

In troubling decision, FDA contracts with company that may have profited from fetal tissue sales
FDA (Image: Wikimedia)

[Ed. – Carelessness on the part of the government or just indifference?]

Earlier this week, CNS News reported that the U.S. Food and Drug Administration recently signed a one-year, $15,900 contract with Advanced Bioscience Resources to acquire human fetal tissue “for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system.”

According to the government’s presolicitation notice, “ABR is the only company in the U.S. capable of supplying” the fetal tissue and “no other company or organization is capable of fulfilling the need.”

In 2015, the Center for Medical Progress released disturbing undercover videos of abortion industry representatives discussing the sale of aborted baby body parts. The ensuing outrage spawned congressional investigation in the House and Senate and resulted in multiple criminal referrals.

Trending: Mother needs something to throw during argument, chooses her baby

ABR is among the entities under referral for criminal investigation for possibly profiting from the sale of fetal tissue from aborted babies. Among its sources for fetal tissue are Planned Parenthood-affiliated clinics.

Continue reading →

For your convenience, you may leave commments below using either the Spot.IM commenting system or the Facebook commenting system. If Spot.IM is not appearing for you, please disable AdBlock to leave a comment.


Commenting Policy

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please hover over that comment, click the ∨ icon, and mark it as spam. Thank you for partnering with us to maintain fruitful conversation.